Epilepsy and the Interictal State : Co-Morbidities and Quality of Life.

Cover -- Title Page -- Copyright -- Contents -- List of contributors -- Preface -- Section I Quality of life and the interictal state in epilepsy -- Chapter 1 Quality of life in epilepsy: the key importance of the interictal state -- Introduction -- Tools for measuring QOL -- Ictal factors: seizure frequency and severity -- Interictal factors -- Conclusion -- References -- Chapter 2 Comorbidities in epilepsy: range and impact -- Introduction -- Psychosocial factors -- Social support -- Socioeconomic factors -- Somatic health issues -- Physician-patient interactions -- Health behavior and lifestyle factors -- AEDs and nutritional factors -- AEDs and comorbidity risk factors -- Conclusion -- References -- Chapter 3 Epilepsy, comorbidities, and consequences: implications for understanding and combating stigma -- Disclaimer -- Introduction -- Understanding stigma -- The burden of epilepsy stigma -- Epilepsy comorbidities and stigma -- Impact on QOL -- Combating stigma -- References -- Section II Cognition and epilepsy -- Chapter 4 Causes and types of cognitive domain impairments in epilepsy -- Impairment of consciousness in epilepsy -- Ictal cognitive impairments due to nonconvulsive status epilepticus -- Memory and dysexecutive impairments in epilepsy -- Attention deficit/hyperactivity disorder, disordered attention, and epilepsy -- Behavioral and developmental disorders in epilepsy -- Chapter 5 Cognitive effects of epilepsy therapies -- Introduction -- Cognitive effects of anticonvulsant medications -- Cognitive effects of surgical epilepsy treatments -- Treatment of cognitive deficits -- Conclusion -- References -- Chapter 6 Autism and epilepsy -- Introduction -- Autism: definition, subtypes, and etiology -- Autism in epilepsy -- Epilepsy and epileptiform EEG abnormalities in autism -- Conclusion -- References.

Chapter 7 Cognitive rehabilitation strategies in epilepsy -- Introduction -- Background -- Cognitive rehabilitation -- Assessment -- Primary cognitive complaints -- Other important factors -- Burden of normalcy -- Conclusion -- References -- Section III Adverse effects of epilepsy therapies -- Chapter 8 Adverse effects in epilepsy: recognition, measurement, and taxonomy -- Introduction -- Assessing antiepileptic medication adverse effects: a historical perspective -- Available instruments for assessment of seizure medication adverse effects -- Classification and taxonomy of adverse seizure medication effects -- Clinical utility of systematic screening for adverse effects -- References -- Chapter 9 Clinically important antiepileptic drug interactions and their influence on adverse effects in epilepsy -- Background -- Epidemiology -- Pathophysiology/etiology -- Diagnosis -- Practical aspects and treatment -- Pearls -- References -- Chapter 10 Minimizing the adverse effects of epilepsy therapies: principles and practice -- Introduction -- Adverse effects encountered during antiepileptic drug polytherapy -- Defining and identifying antiepileptic drug adverse effects -- General strategies for minimzing adverse effects -- Drug selection principles for minimizing adverse effects -- Practical approaches to minimizing adverse effects during antiepileptic drug polytherapy -- Conclusion -- References -- Chapter 11 Idiosyncratic adverse side effects of antiepileptic drugs: risk, prevention, and counseling -- Introduction -- Therapeutic considerations and idiosyncratic adverse drug reactions in infantile spasms treatment -- Therapeutic considerations and idiosyncratic adverse drug reactions in Lennox-Gastaut syndrome treatment -- Idiosyncratic allergic rash risk associated with antiepileptic drug therapies.

Idiosyncratic adverse effects associated with valproate and ethosuximide -- Idiosyncratic adverse effects associated with carbamazepine and oxcarbazepine -- Idiosyncratic adverse effects associated with topiramate and zonisamide -- Idiosyncratic adverse effects associated with rufinamide -- Idiosyncratic adverse effects associated with ezogabine -- Conclusion -- References -- Chapter 12 Antiepileptic drug therapy and fetal development -- Introduction -- The burden of epilepsy -- Epidemiology -- Pregnancy registers -- Polytherapy considerations -- Folate -- Results emerging from studies of AED exposure in pregnancy -- Teratogenicity of individual AEDs -- Cognitive developmental defects and AED exposure -- Conclusion -- Acknowledgments -- References -- Section IV Mood state, psychiatric comorbidity, and epilepsy -- Chapter 13 Mood state, anxiety, and psychosis in epilepsy -- Introduction -- Mood disorders and epilepsy -- Anxiety disorders and epilepsy -- Practical advice/pearls -- Psychoses and epilepsy -- Practical advice/pearls -- Conclusion -- References -- Chapter 14 The contribution of sleep and anxiety disorders to quality of life in people with epilepsy -- Introduction -- Anxiety and epilepsy -- Investigating the prevalence and nature of psychological distress in people with epilepsy -- What does this study add to the current picture? -- Conclusion -- Acknowledgements -- References -- Chapter 15 Epilepsy and personality -- Introduction -- Personality assessment in epilepsy -- TLE and Geschwind syndrome -- JME and Janz syndrome -- Studies of personality disorder in patients with mixed epilepsy -- Effect of epilepsy surgery -- Relationship between personality and QOL -- Conclusion -- References -- Chapter 16 Psychogenic attacks and epilepsy -- Introduction -- Epidemiology -- Pathophysiology -- Etiology -- Clinical features.

Diagnostic investigations -- Treatment -- Prognosis -- Follow-up -- The grey zone: driving and psychogenic attacks -- Conclusion -- References -- Section V General health and epilepsy -- Chapter 17 Obesity and epilepsy -- Introduction -- Epidemiology -- Pathophysiology -- Evaluation -- Treatment -- Prognosis -- References -- Chapter 18 Epilepsy in the elderly: vascular disease, the aging brain, and selection of appropriate therapies -- Introduction -- Epidemiology/etiologies/ pathophysiology -- Diagnostic evaluation -- Treatment -- Psychosocial implications of seizures in older people -- Practical advice and pearls -- References -- Chapter 19 Balance disorders and falls in epilepsy -- Introduction -- Epidemiology -- Pathophysiology -- Etiology -- Diagnosis/evaluation -- Management -- Conclusion -- References -- Chapter 20 Bone health in epilepsy -- Introduction -- Fracture rates -- Epidemiology -- Pathophysiology -- Diagnosis and evaluation -- Management -- Prognosis -- References -- Chapter 21 Sleep and epilepsy -- Introduction -- Pathophysiology -- The common sleep-related epilepsies -- Evaluation and differential diagnosis -- Treatment -- Conclusion -- References -- Chapter 22 Use of complementary and alternative medicine in epilepsy -- Introduction -- Use of CAM by people with epilepsy in Western countries -- Mind-body medicine -- Biologically-based practices -- Energy medicine -- Whole medical systems -- Conclusion -- References -- Chapter 23 Epilepsy and alcohol and substance abuse -- Introduction -- Alcohol -- Marijuana -- Cocaine -- Heroin -- Amphetamines, methamphetamine, and MDMA -- Benzodiazepines and barbiturates -- Drug use in persons with preexisting epilepsy -- Conclusion -- Practical advice and pearls -- References -- Chapter 24 Driving, employment, and related issues in epilepsy -- Introduction -- Driving -- Employment.

Recreation and socialization -- Conclusion -- References -- Index -- EULA.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.